Detalhe da pesquisa
1.
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial.
Arterioscler Thromb Vasc Biol
; 43(8): 1572-1582, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381988
2.
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.
Circulation
; 140(18): 1463-1476, 2019 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31524498
3.
Bicuspid Aortic Valve Endocarditis Caused by Streptococcus sanguinis: A Case Report.
Cureus
; 16(1): e52488, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38371036
4.
Atypical Takotsubo Cardiomyopathy Precipitated by Gastrointestinal Bleeding: Review of the Pathophysiology.
Cureus
; 15(2): e34515, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36874316
5.
Incidental Finding of Thoracic Aortic Dissection in a Patient Post-Coronary Artery Bypass Graft Surgery.
Cureus
; 15(6): e40443, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37456414
6.
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
Nat Med
; 27(11): 1954-1960, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711976
7.
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Diabetes Endocrinol
; 9(9): 586-594, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302745
8.
Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors.
J Virol
; 76(7): 3105-13, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11884535